STEINBEIS GMBH & CO KG FUR TECHNOLOGIE TRANSFER

Their core work

Steinbeis is one of Germany's largest technology transfer organizations, bridging academic research and industrial application across multiple sectors. Within H2020, their strongest contribution lies in chemical risk assessment and computational toxicology, where they support large European consortia in developing mechanism-based testing strategies and regulatory-grade safety frameworks. They also contribute to energy efficiency actions for cities and antimicrobial surface technologies, reflecting their broad technology transfer mandate. Their role is typically to translate scientific methods into practical, industry-ready tools and processes.

What they specialise in

How they've shifted over time

In their earlier H2020 work (2015–2018), Steinbeis engaged in foundational toxicology research — systems toxicology, molecular mechanisms, cheminformatics, and computational modelling of dose-response relationships via EU-ToxRisk. By 2021, their focus shifted decisively toward translating these methods into regulatory-ready frameworks: RISK-HUNT3R emphasizes next-generation risk assessment, quantitative AOP networks, and regulatory acceptance. This mirrors the broader European trajectory from research-phase safety science toward practical implementation in chemical regulation.

Steinbeis is moving from generating toxicological knowledge to packaging it for regulatory uptake — making them increasingly relevant for projects that need to bridge science and EU chemical safety policy.

How they like to work

Steinbeis operates exclusively as a participant, never as coordinator, which is consistent with their technology transfer identity — they embed into consortia to provide specific methodological or translational expertise. With 88 unique partners across 19 countries from just 4 projects, they work in large, multinational consortia (EU-ToxRisk alone was a flagship program with dozens of partners). This makes them experienced at operating in complex, multi-partner environments and easy to integrate into new consortia.

Despite only 4 projects, Steinbeis has built a remarkably broad network of 88 partners across 19 countries, driven primarily by participation in large flagship programs like EU-ToxRisk. Their network spans most of Europe with no narrow geographic concentration.

What sets them apart

Steinbeis occupies a distinctive niche as a technology transfer specialist within the chemical safety and toxicology space — not a university generating fundamental research, and not a company needing regulatory compliance, but the bridge between the two. Their dual presence in large-scale toxicology flagships and practical urban energy or materials projects demonstrates an unusual ability to operate across very different domains. For consortium builders, they offer a proven translation function: turning complex scientific outputs into tools and processes that regulators and industry can actually use.

Highlights from their portfolio

• EU-ToxRisk
  European flagship toxicology program and Steinbeis's largest H2020 engagement (EUR 804K), positioning them at the center of Europe's mechanism-based toxicity testing agenda.
• RISK-HUNT3R
  Running until 2026 with EUR 695K funding, this is their most recent and forward-looking project, directly targeting regulatory acceptance of next-generation chemical risk assessment.